| Wed 20 October |
| Room 3A | Room 3B | Hall 1B | Hall 1C | Room 11B - Workshop | Room 11C - Workshop | DAY 2 | ||
8:00 | Event Registration | 8:00: | |||||||
8:05: | 8:05: | ||||||||
8:10: | 8:10: | ||||||||
8:15: | 8:15: | ||||||||
8:20: | 8:20: | ||||||||
8:25: | 8:25: | ||||||||
8:30: | 8:30: | ||||||||
8:35: | 8:35: | ||||||||
8:40: | 8:40: | ||||||||
8:45: | 8:45: | ||||||||
8:50: | Conference Welcome and Plenary Keynote Introduction |
8:50: | |||||||
8:55: | 8:55: | ||||||||
9:00 | Plenary Keynote Presentation Looking ahead: what is next for AI in drug discovery? 09:00 (50 mins) Guido Lanza, Valo Health |
9:00: | |||||||
9:05: | 9:05: | ||||||||
9:10: | 9:10: | ||||||||
9:15: | 9:15: | ||||||||
9:20: | 9:20: | ||||||||
9:25: | 9:25: | ||||||||
9:30: | 9:30: | ||||||||
9:35: | 9:35: | ||||||||
9:40: | 9:40: | ||||||||
9:45: | 9:45: | ||||||||
9:50: | Early Career Professional Impact Award - Sponsored by SelectScience ![]() 09:50 (20 mins) Laura Ajram, Medicines Discovery Catapult |
9:50: | |||||||
9:55: | 9:55: | ||||||||
10:00 | 10:00 | ||||||||
10:05 | 10:05 | ||||||||
10:10 | Refreshment Break | 10:10 | |||||||
10:15 | 10:15 | ||||||||
10:20 | 10:20 | ||||||||
10:25 | 10:25 | ||||||||
10:30 | 10:30 | ||||||||
10:35 | 10:35 | ||||||||
10:40 | 10:40 | ||||||||
10:45 | 10:45 | ||||||||
10:50 | Screening Innovation to Enhance Drug Discovery - sponsored by Domainex Chairs: Ian Storer, AstraZeneca Jeff Jerman, Lifearc |
Innovative Strategies Supporting Drug Discovery Chairs: Kenny Simmen, Johnson & Johnson Innovation Laura Dickens, UKRI - Medical Research Council |
Disruptive technologies Chairs: Carolina Wählby, Uppsala University Mark Roberts, Tessella |
The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable Chairs: Nura Mohamed, Imperial College London |
Workshop ![]() 10:50 (80 mins) Tilmann Buerckstuemmer — Aelian Biotechnology |
Workshop The challenges of cell models: Novel approaches and tools for basic research and drug discovery 10:50 (60 mins) Zoe Nilsson — bit.bio |
10:50 | ||
10:55 | 10:55 | ||||||||
11:00 | Screening Innovation to Enhance Drug Discovery - sponsored by Domainex ![]() 11:00 (30 mins) Markus Ralser, Crick Institute / Dept Biochemistry, Berlin ![]() 11:30 (30 mins) Richard Cuthbert — Bio-Rad |
Innovative Strategies Supporting Drug Discovery ![]() 11:00 (30 mins) Jonathan Pearce, UKRI- Medical Research Council ![]() 11:30 (30 mins) Andrew Scott — Malvern Panalytical |
Disruptive technologies ![]() 11:00 (30 mins) Mats Nilsson, SciLifeLab ![]() 11:30 (30 mins) Sun Yung — Nexcelom from PerkinElmer |
The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable ![]() 11:00 (30 mins) Daren Austin, GlaxoSmithKline ![]() 11:30 (30 mins) Lotta Räty — Miltenyi Biotec |
11:00 | ||||
11:05 | 11:05 | ||||||||
11:10 | 11:10 | ||||||||
11:15 | 11:15 | ||||||||
11:20 | 11:20 | ||||||||
11:25 | 11:25 | ||||||||
11:30 | 11:30 | ||||||||
11:35 | 11:35 | ||||||||
11:40 | 11:40 | ||||||||
11:45 | 11:45 | ||||||||
11:50 | 11:50 | ||||||||
11:55 | 11:55 | ||||||||
12:00 | Screening Innovation to Enhance Drug Discovery - sponsored by Domainex ![]() 12:00 (30 mins) James Robinson, AstraZeneca ![]() 12:30 (15 mins) Fredrik Rahm — Pelago Bioscience AB ![]() 12:45 (5 mins) Mourad Ferhat — ISOPLEXIS ![]() 12:50 (5 mins) Gary Allenby — Aurelia Bioscience ![]() 12:55 (5 mins) Ravindra Chaudhari — NanoTemper Technologies |
Innovative Strategies Supporting Drug Discovery ![]() 12:00 (30 mins) Annette Crosse, Egality ![]() 12:30 (15 mins) Charlotte Kopitz — NUVISAN ![]() 12:45 (5 mins) Matt Taylor — Thermo Fisher Scientific ![]() 12:50 (5 mins) Mark Graham — Cytiva ![]() 12:55 (5 mins) Tamsin Lamont — Collaborative Drug Discovery |
Disruptive technologies ![]() 12:00 (30 mins) Ilaria Testa, SciLifeLab Francesca Pennacchietti ![]() 12:30 (15 mins) Tilmann Buerckstuemmer — Aelian Biotechnology ![]() 12:45 (5 mins) Tali Bloom — Benchling ![]() 12:50 (5 mins) Sylwia Mankowska — HexagonFab ![]() 12:55 (5 mins) Paul Gallant — LifeNet Health LifeSciences |
The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable ![]() 12:00 (30 mins) Terence Hébert, McGill University ![]() 12:30 (15 mins) David Madge — WuXi AppTec ![]() 12:45 (5 mins) Ellen Berg — Eurofins Discovery Bioluminescent Tools & Approaches for RAS Pathway Drug Discovery 12:50 (5 mins) Craig Malcolm — Promega UK Ltd ![]() 12:55 (5 mins) Tomasz Kostrzewski — CN Bio |
12:00 | ||||
12:05 | 12:05 | ||||||||
12:10 | 12:10 | ||||||||
12:15 | 12:15 | ||||||||
12:20 | 12:20 | ||||||||
12:25 | 12:25 | ||||||||
12:30 | 12:30 | ||||||||
12:35 | 12:35 | ||||||||
12:40 | 12:40 | ||||||||
12:45 | 12:45 | ||||||||
12:50 | 12:50 | ||||||||
12:55 | 12:55 | ||||||||
1:00 | Refreshment Break | Workshop Chairs: Lilian Hunt, EDIS, Wellcome Trust ![]() 13:00 (60 mins) Lilian Hunt, EDIS, Wellcome Trust |
1:00: | ||||||
1:05: | 1:05: | ||||||||
1:10: | 1:10: | ||||||||
1:15: | 1:15: | ||||||||
1:20: | 1:20: | ||||||||
1:25: | 1:25: | ||||||||
1:30: | 1:30: | ||||||||
1:35: | 1:35: | ||||||||
1:40: | 1:40: | ||||||||
1:45: | 1:45: | ||||||||
1:50: | 1:50: | ||||||||
1:55: | 1:55: | ||||||||
2:00 | 2:00: | ||||||||
2:05: | 2:05: | ||||||||
2:10: | 2:10: | ||||||||
2:15: | 2:15: | ||||||||
2:20: | 2:20: | ||||||||
2:25: | 2:25: | ||||||||
2:30: | Screening Innovation to Enhance Drug Discovery - sponsored by Domainex Generation of fully human antibodies using high throughput IntelliSelect® Technology Platforms at LifeArc 14:30 (30 mins) Preeti Bakrania, LifeArc Alignment of Chemogenomic and Functional Genomic screening for target ID 15:00 (30 mins) Joanna Redmond, GlaxoSmithKline |
Innovative Strategies Supporting Drug Discovery ![]() 14:30 (30 mins) Peter Simpson, Medicines Discovery Catapult Open drug discovery on the edge - the COVID Mooonshot's quest for an antiviral pill 15:00 (30 mins) Frank von Delft, Diamond |
Disruptive technologies ![]() 14:30 (30 mins) Ben Slater, Materials Innovation Factory (MIF) ![]() 15:00 (30 mins) Sam Genway, Capgemini Engineering |
The British Pharmacological Society - Opportunities and Challenges of Drugging the Undruggable Effects of small molecule compounds targeting osteoclasts against RA bone destruction 14:30 (30 mins) Yanhui Tan, Guangxi Normal University, Guilin, China ![]() 15:00 (30 mins) Rongjun Chen, Imperial College London |
Workshop Learn to Learn 14:30 (90 mins) Chris Williams, Questae Coaching & Consulting Ltd |
2:30: | |||
2:35: | 2:35: | ||||||||
2:40: | 2:40: | ||||||||
2:45: | 2:45: | ||||||||
2:50: | 2:50: | ||||||||
2:55: | 2:55: | ||||||||
3:00 | 3:00: | ||||||||
3:05: | 3:05: | ||||||||
3:10: | 3:10: | ||||||||
3:15: | 3:15: | ||||||||
3:20: | 3:20: | ||||||||
3:25: | 3:25: | ||||||||
3:30: | Comfort Break | 3:30: | |||||||
3:35: | 3:35: | ||||||||
3:40: | Screening Innovation to Enhance Drug Discovery - sponsored by Domainex A Huntington’s disease embryonic stem cell phenotypic HTS to identify small molecule modulators of mutant HTT 15:40 (30 mins) Marta Stebbeds, Discovery from Charles River High-throughput PROTAC synthesis for direct, biological assaying 16:10 (30 mins) David Battersby, GlaxoSmithKline |
Innovative Strategies Supporting Drug Discovery ![]() 15:40 (30 mins) Timur Avkiran ![]() 16:10 (30 mins) Helen Horton, Touchlight |
Disruptive technologies ![]() 15:40 (30 mins) Pedro Beltrao, EMBL-EBI ![]() 16:10 (30 mins) Hugo Ceulemans, Janssen Pharmaceutica |
3:40: | |||||
3:45: | 3:45: | ||||||||
3:50: | 3:50: | ||||||||
3:55: | 3:55: | ||||||||
4:00 | 4:00: | ||||||||
4:05: | 4:05: | ||||||||
4:10: | 4:10: | ||||||||
4:15: | 4:15: | ||||||||
4:20: | 4:20: | ||||||||
4:25: | 4:25: | ||||||||
4:30: | 4:30: | ||||||||
4:35: | 4:35: | ||||||||
4:40: | Conference Close and Awards |
4:40: | |||||||
4:45: | 4:45: | ||||||||
4:50: | 4:50: | ||||||||
4:55: | 4:55: | ||||||||
5:00 | 5:00: | ||||||||
5:05: | 5:05: | ||||||||
5:10: | 5:10: | ||||||||
5:15: | 5:15: | ||||||||
5:20: | 5:20: | ||||||||
5:25: | 5:25: | ||||||||
5:30: | 5:30: | ||||||||
5:35: | 5:35: | ||||||||
5:40: | 5:40: | ||||||||
5:45: | 5:45: | ||||||||
5:50: | 5:50: | ||||||||
5:55: | 5:55: | ||||||||
6:00 | 6:00: | ||||||||
6:05: | 6:05: | ||||||||
6:10: | 6:10: | ||||||||
6:15: | 6:15: | ||||||||
6:20: | 6:20: | ||||||||
6:25: | 6:25: | ||||||||
6:30: | 6:30: | ||||||||
6:35: | 6:35: | ||||||||
6:40: | 6:40: | ||||||||
6:45: | 6:45: | ||||||||
6:50: | 6:50: | ||||||||
6:55: | 6:55: | ||||||||
7:00 | 7:00: |